COMPASS Pathways Plc (NASDAQ:CMPS) has announced an expansion of its Discovery Centre through a partnership with leading labs at Medical College of Wisconsin (MCW) and UC San Diego, School of Medicine.
Discovery center to develop psychedelic compounds
Following the collaborations, MCW’s Assistant Professor, Department of Cell Biology, Neurobiology and Anatomy, John McCorvy, and US San Diego’s Psychiatry Associate Professor Adam Halberstadt and their teams will join University of the Sciences (Philadelphia) Assistant Pharmaceutical Sciences Jason Wallach at the Discovery Center. In August last year, the company established the Discovery Centre through a sponsored research agreement with the University of Sciences. Jason Wallach’s lab at the University of the Sciences is leading the center, and it is now expanding the work across the US with John McCorvy in Wisconsin and Adam Halberstadt in San Diego. The scientists will develop novel optimized psychedelic compounds to address the unmet medical need. The company will be the exclusive licensee of the compounds.
Lars Wilde, COMPASS’s Chief Business Officer, and Co-founder said this is an exciting collaboration with leading scientists in psychedelic research. Wilde said that the Discovery Centre’s focus will be preclinical research for novel psychedelic compounds that address unmet needs for various mental health indications.
COMPASS establishes Center of Excellence in Maryland
COMPASS has also announced establishing a Centre of Excellence in partnership with The Sheppard Pratt Institute for advanced Diagnostics and Therapeutics in Maryland. The Centre of Excellence is a model clinic of the future showing the best thinking in tech, sciences, design, and therapy. It will operate as a research facility and innovation lab generating evidence that will define therapy models in mental health. Equally, the center will carry clinical trials, train and certify therapists, and prototype digital solutions to enhance patients experience
The company’s CEO George Goldsmith said that they are looking to transform mental health care, which currently is not good enough for most people. Sheppard Pratt has a history of excellence in clinical service delivery and commitment to its patient community.
